Monte Rosa Therapeutics Inc (GLUE) — Free Cash Flow Generation Index

Latest as of September 2025: 0.99x

Monte Rosa Therapeutics Inc (GLUE) has a Free Cash Flow Generation Index of 0.99x as of September 2025. Free cash flow of $99.78 Million represents 1% of operating cash flow ($100.43 Million). Read Monte Rosa Therapeutics Inc (GLUE) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.99x

Free Cash Flow / Operating CF

Free Cash Flow

$99.78 Million

USD

Operating Cash Flow

$100.43 Million

USD

Capital Expenditures

$651.00K

USD

Monte Rosa Therapeutics Inc Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for Monte Rosa Therapeutics Inc across 1 annual periods. Explore GLUE capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Monte Rosa Therapeutics Inc (2024–2024)

Year-by-year Free Cash Flow Generation Index for Monte Rosa Therapeutics Inc. For the full company profile including market capitalisation, see GLUE market cap.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2024	0.91x	$38.01 Million	$42.00 Million	$3.99 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).